Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00959283 · ClinicalTrials.gov registry record
Study of Blood Samples From Newborns With Down Syndrome
A clinical trial of Myeloid Proliferations Associated With Down Syndrome, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 180
- Enrollment target
- 20
- Study locations
NCT00959283: Completed study of Myeloid Proliferations Associated With Down Syndrome, sponsored by Children's Oncology Group.
NCT00959283 is a study of Myeloid Proliferations Associated With Down Syndrome that has completed, run by Children's Oncology Group. The registered enrollment target is 180 participants. The trial reports 20 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00959283, a study of Myeloid Proliferations Associated With Down Syndrome, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 180 participants
- Enrollment target
- 20
- Study locations
Study Summary
This research study is looking at blood samples from newborns with Down syndrome. Studying the genes expressed in samples of blood from patients with Down syndrome may help doctors identify biomarkers related to cancer.
Conditions Studied
Interventions
- OTHER Diagnostic Laboratory Biomarker Analysis
- OTHER Pharmacological Study
Study Locations (20)
California
- Kaiser Permanente Downey Medical Center - Downey
- Loma Linda University Medical Center - Loma Linda
- Miller Children's and Women's Hospital Long Beach - Long Beach
- Children's Hospital Los Angeles - Los Angeles
- Cedars Sinai Medical Center - Los Angeles
- Mattel Children's Hospital UCLA - Los Angeles
- UCLA / Jonsson Comprehensive Cancer Center - Los Angeles
- Valley Children's Hospital - Madera
- Children's Hospital and Research Center at Oakland - Oakland
- Kaiser Permanente-Oakland - Oakland
- Children's Hospital of Orange County - Orange
- Lucile Packard Children's Hospital Stanford University - Palo Alto
- Sutter Medical Center Sacramento - Sacramento
Alabama
- Children's Hospital of Alabama - Birmingham
- University of Alabama at Birmingham Cancer Center - Birmingham
- USA Health Strada Patient Care Center - Mobile
Arkansas
- Arkansas Children's Hospital - Little Rock
- University of Arkansas for Medical Sciences - Little Rock
Alaska
- Providence Alaska Medical Center - Anchorage
Arizona
- Phoenix Childrens Hospital - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2009-02-23 |
| Est. Completion | 2023-09-30 |
What the finished NCT00959283 record still lists
NCT00959283 is an observational study that tracks outcomes without assigning an intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Myeloid Proliferations Associated With Down Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Diagnostic Laboratory Biomarker Analysis is the first listed.
NCT00959283 names 20 study sites across 5 states, led by California, Alabama, Arkansas.
Frequently Asked Questions
What is clinical trial NCT00959283 about?
NCT00959283 is a clinical study titled "Study of Blood Samples From Newborns With Down Syndrome". This research study is looking at blood samples from newborns with Down syndrome. Studying the genes expressed in samples of blood from patients with Down syndrome may help doctors identify biomarkers related to cancer.
What is the current status of trial NCT00959283?
This trial is currently completed. The enrollment target is 180 participants. The study started on 2009-02-23. Estimated completion is 2023-09-30.
What conditions does trial NCT00959283 study?
This clinical trial studies the following conditions: Myeloid Proliferations Associated With Down Syndrome.
What interventions are being tested in trial NCT00959283?
The interventions under investigation include: Diagnostic Laboratory Biomarker Analysis (OTHER), Pharmacological Study (OTHER).
Who is sponsoring clinical trial NCT00959283?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00959283 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI